Pharma Digital Health Commercial Assessment

Lupin Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 160 drugs in the United States.

 

Lupin is interested in entering the digital health / digital therapeutic sector

 

DTxCC conducts a commercial assessment to develop a clear understanding of the US marketplace and opportunities for a digital health/therapeutic offering

Go-to-market strategies

• ROI/NPV Investment Evaluation

• Incremental sales forecast

• Supporting evidence/promotions needed for commercial success

• Organizational capabilities needed for commercial success